Literature DB >> 21234675

Antibodies to myelin P0 and ceramide perpetuate neuropathy in long standing treated leprosy patients.

Renuka Raju1, S Karuna Devi, C Mehervani, A Shiva Kumar, A K Meena, P P Reddy, Penaguluru Pranay, Suman Jain, J J Archelos-Gracia, Sujai Suneetha, Lavanya M Suneetha.   

Abstract

Anti neural antibodies are known to play a role in the immunopathogenesis of nerve damage in leprosy and HIV/AIDS. Myelin Protein zero (P0) and ceramide are two nerve components which maintain the integrity of the peripheral nerve. The present study was undertaken to identify antibodies to myelin P0 and ceramide in the sera of treated leprosy patients, HIV positive individuals and healthy subjects using enzyme linked immunosorbant assay (ELISA). The results revealed that treated leprosy patients continue to have significantly elevated myelin P0 and ceramide antibody levels as compared to healthy subjects (P < 0.05). The elevated antibody response to myelin P0 and ceramide in leprosy patients indicate a low grade autoimmune activity that perpetuates nerve damage in treated leprosy. There was no significant difference in the myelin P0 and ceramide antibody levels between HIV positive and healthy subjects (P > 0.05) suggesting that these antibodies do not play a role in early HIV infection.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21234675     DOI: 10.1007/s11064-010-0397-7

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  41 in total

1.  Effect of Mycobacterium leprae on peripheral nerve protein phosphorylation; a preliminary study.

Authors:  L M Suneetha; C K Job; A S Balasubramanian
Journal:  Int J Lepr Other Mycobact Dis       Date:  1996-09

2.  Immunohistochemical analysis of cellular infiltrate and gamma interferon, interleukin-12, and inducible nitric oxide synthase expression in leprosy type 1 (reversal) reactions before and during prednisolone treatment.

Authors:  D Little; S Khanolkar-Young; A Coulthart; S Suneetha; D N Lockwood
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

3.  Thiopalmitoylated peptides from the peripheral nervous system myelin p0 protein: synthesis, characterization, and neuritogenic properties.

Authors:  Wissam Beaino; Elisabeth Trifilieff
Journal:  Bioconjug Chem       Date:  2010-08-18       Impact factor: 4.774

Review 4.  Myelin sheaths: glycoproteins involved in their formation, maintenance and degeneration.

Authors:  R H Quarles
Journal:  Cell Mol Life Sci       Date:  2002-11       Impact factor: 9.261

5.  Protein phosphorylation in human peripheral nerve: altered phosphorylation of a 25-kDa glycoprotein in leprosy.

Authors:  L M Suneetha; R J Korula; A S Balasubramanian
Journal:  Neurochem Res       Date:  1996-06       Impact factor: 3.996

Review 6.  Autoimmune phenomena in leprosy, particularly antinuclear antibodies and rheumatoid factor.

Authors:  I Garcia-De La Torre
Journal:  J Rheumatol       Date:  1993-05       Impact factor: 4.666

7.  Regeneration at the predilective damage sites of nerve trunks in treated leprosy.

Authors:  T L Miko; S E Gschmeissner; C le Maitre; Y Kinfu; R Kazen; J H Pereira
Journal:  Lepr Rev       Date:  1993-12       Impact factor: 0.537

8.  Peripheral nerve function in HIV infection: clinical, electrophysiologic, and laboratory findings.

Authors:  M Tagliati; J Grinnell; J Godbold; D M Simpson
Journal:  Arch Neurol       Date:  1999-01

9.  FK506 is neuroprotective in a model of antiretroviral toxic neuropathy.

Authors:  Sanjay C Keswani; Bani Chander; Chiler Hasan; John W Griffin; Justin C McArthur; Ahmet Hoke
Journal:  Ann Neurol       Date:  2003-01       Impact factor: 10.422

Review 10.  Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes.

Authors:  Scott B Halstead; Suresh Mahalingam; Mary A Marovich; Sukathida Ubol; David M Mosser
Journal:  Lancet Infect Dis       Date:  2010-10       Impact factor: 25.071

View more
  4 in total

1.  The DermLep Study I: Results of Prospective Nation-Wide Survey of the Number & Profile of Leprosy Patients seen by Dermatologists in India.

Authors:  P Narasimha Rao; Santoshdev Rathod; Sujai Suneetha; Sunil Dogra; Sunil Kumar Gupta; Rita Vora; Shushruth Kamoji; Swagta Tambe
Journal:  Indian Dermatol Online J       Date:  2020-09-19

2.  Dermlep Study Part 3: Post-RFT Events in Leprosy Patients Presenting to Dermatologists.

Authors:  P Narasimha Rao; Sujai Suneetha; Santoshdev P Rathod; Tarun Narang; Sunil Dogra; Archana Singal; Sunilkumar Gupta; Rita Vora
Journal:  Indian Dermatol Online J       Date:  2022-05-05

3.  Serological responses to prednisolone treatment in leprosy reactions: study of TNF-α, antibodies to phenolic glycolipid-1, lipoarabinomanan, ceramide and S100-B.

Authors:  Renuka Raju; Sujai Suneetha; Rupendra S Jadhav; MeherVani Chaduvula; Sara Atkinson; Suman Jain; Leo H Visser; Loretta Das; Ravindra Panhalkar; Vidyagouri Shinde; Parphananda P Reddy; Pramila Barkataki; Diana Nj Lockwood; Wim H Van Brakel; Lavanya M Suneetha
Journal:  Lipids Health Dis       Date:  2014-07-28       Impact factor: 3.876

4.  Insights from the sequence similarity of Zika virus proteins with the Human nerve proteins.

Authors:  Prasanna Marsakatla; Sujai Suneetha; Joshua Lee; Paari Dominic Swaminathan; Logeshwaran Vasudevan; Rachael Supriya; Lavanya Moses Suneetha
Journal:  Bioinformation       Date:  2018-05-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.